UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000029849
Receipt No. R000034018
Official scientific title of the study The effect of a combination of dietary intervention and functional therapy using ingredient analytical instrument in fatty liver patients: a randomized controlled trial.
Date of disclosure of the study information 2017/11/07
Last modified on 2018/11/07 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The effect of a combination of dietary intervention and functional therapy using ingredient analytical instrument in fatty liver patients: a randomized controlled trial.
Title of the study (Brief title) Dietary and functional intervention study.
Region
Japan

Condition
Condition fatty liver diseases
Non-alcoholic Fatty Liver Diseases
Non-alcoholic steatohepatitis
Classification by specialty
Medicine in general Hepato-biliary-pancreatic medicine Endocrinology and Metabolism
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Non-alcoholic fatty liver disease (NAFLD) and a nonalcoholic steatohepatitis (NASH) is required management of diet, and recommended to do a continued exercise. Purpose of this study is to explore the efficacy of the multidisciplinary team approach to support diet therapy accompanying nutritional guidance and exercise instruction accompanying exercise instruction together.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase

Assessment
Primary outcomes Changes from baseline of skeletal muscle mass; body fat mass; basal metabolism rate; and visceral fat area, at one, two, three, six, nine, and 12 months after the start of the intervention.
Key secondary outcomes Motor function test (6 minutes walking distance, grip strength,Knee extension muscle strength), blood biochemical test (AST,ALT, GTP, TG,HDL-cho LDL-cho, BS, insulin, iron, ferritin, FFA Hyaluronic acid, type IV collagen 7S, etc.), abdominal supersonic Wave test (liver hardness, rate of change of hepatic fat mass).

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment No need to know

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Behavior,custom
Interventions/Control_1 Educational intervention
Interventions/Control_2 12 months
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
75 years-old >
Gender Male and Female
Key inclusion criteria 1. Patient diagnosed as fatty liver
2. Patient aged over 20 years old and under 75
3. PS 0 - 1 (ECOG)
4. Patient can intake orally
5. Informed Consent has been obtained in writing form.by himself / herself about examination participation
Key exclusion criteria 1. Patient who has been infected with hepatitis virus
2. Patient has a clear drinking history (Alcohol amount: over 20 g / day)
3. patient who has difficulties in doing exercise, such as any joint pain, kidney dysfunction or heart disease
4. Patient who has poorly controlled diabetes
5. Patient who was judged as inappropriate for this research by physichans.
Target sample size 26

Research contact person
Name of lead principal investigator Masashi FURUTA
Organization National Center for Global Health and Medicine
Division name The Research Center for Hepatitis and Immunology
Address 1-7-1 Kohnodai, Ichikawa-City, Chiba, Japan
TEL 047-372-3501
Email masashi.furuta@med.toho-u.ac.jp

Public contact
Name of contact person Masashi FURUTA
Organization National Center for Global Health and Medicine
Division name The Research Center for Hepatitis and Immunology
Address 1-7-1 Kohnodai, Ichikawa-City, Chiba, Japan
TEL 047-372-3501
Homepage URL
Email masashi.furuta@med.toho-u.ac.jp

Sponsor
Institute National Center for Global Health and Medicine
The Research Center for Hepatitis and Immunology
Department of Liver Disease
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 国立国際医療研究センター国府台病院(千葉県)
National Center for Global Health and Medicine Konodai Hospital

Other administrative information
Date of disclosure of the study information
2017 Year 11 Month 07 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 05 Month 22 Day
Anticipated trial start date
2014 Year 05 Month 22 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 11 Month 06 Day
Last modified on
2018 Year 11 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000034018